New Jersey S 4350: Places $100 cap on amount paid by covered persons for purchase of insulin drugs; requires Division of Consumer Affairs to investigate insulin prices.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2020-01-09)

State: New Jersey · Session: 218 · Bill: S 4350

Subjects: CONSUMER PRO, DISEASE, HEALTH INSUR, PHARMACEUTIC

Sponsors: Lagana, Joseph A., Vitale, Joseph F., Gill, Nia H.

View New Jersey S 4350 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.